AI Engines For more Details: Perplexity Kagi Labs You
Antihistamine Action: Pheniramine maleate blocks the action of histamine, a substance in the body that causes allergic symptoms such as itching, sneezing, runny nose, and watery eyes. By inhibiting histamine receptors, pheniramine reduces these symptoms and provides relief from allergic reactions.
Allergy Relief: Pheniramine maleate is commonly used to alleviate symptoms of allergic rhinitis (hay fever), including nasal congestion, itching, sneezing, and runny nose. It can also help relieve symptoms of allergic conjunctivitis (eye allergies) such as redness, itching, and tearing.
Cold and Flu Relief: Pheniramine maleate is often included in over-the-counter cold and flu medications to help relieve symptoms such as nasal congestion, sneezing, and runny nose. It may also help reduce itching and watery eyes associated with the common cold.
Sedation: Pheniramine maleate has sedating effects, which can help improve sleep quality in individuals experiencing symptoms of allergies or the common cold. However, this sedative effect may also cause drowsiness and impair cognitive function, particularly in sensitive individuals.
Dizziness and Drowsiness: Common side effects of pheniramine maleate include dizziness and drowsiness. Patients should use caution when driving, operating machinery, or performing tasks that require mental alertness until they know how the medication affects them.
Dry Mouth: Pheniramine may cause dry mouth due to its anticholinergic effects, which reduce saliva production. Patients should stay hydrated and consider using sugar-free lozenges or chewing gum to alleviate dry mouth symptoms.
Urinary Retention: Pheniramine maleate can impair bladder function and lead to urinary retention, particularly in men with prostatic hypertrophy or individuals with pre-existing urinary issues. Patients should be monitored for urinary symptoms and advised to seek medical attention if they experience difficulty urinating.
Constipation: Anticholinergic medications like pheniramine can slow down bowel movements and lead to constipation in some individuals. Increasing fluid intake, dietary fiber, and physical activity may help alleviate constipation symptoms.
Blurred Vision: Pheniramine may cause temporary blurred vision or difficulty focusing, particularly at higher doses. Patients should avoid activities that require clear vision, such as driving or operating machinery, until their vision returns to normal.
Drug Interactions: Pheniramine maleate may interact with other medications, including central nervous system depressants (e.g., alcohol, benzodiazepines, opioids), leading to additive sedative effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.
Rank | Probiotic | Impact |
---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
ADHD | 0.5 | 0 | 0 |
Allergic Rhinitis (Hay Fever) | 0.1 | 0.1 | |
Allergies | 0.1 | 1 | -9 |
Allergy to milk products | 0.6 | 0.6 | |
Alzheimer's disease | 0.7 | 0.7 | 0 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.2 | 0.5 | -1.5 |
Ankylosing spondylitis | 0.6 | -0.6 | |
Anorexia Nervosa | 0.6 | -0.6 | |
Asthma | 0.1 | -0.1 | |
Atherosclerosis | 0.5 | 0.5 | |
Atrial fibrillation | 0.6 | 0.1 | 5 |
Autism | 0.6 | 0.7 | -0.17 |
Bipolar Disorder | 0.6 | 0.5 | 0.2 |
Brain Trauma | 0.1 | -0.1 | |
Carcinoma | 0.6 | 0.6 | 0 |
Celiac Disease | 0.1 | 0.6 | -5 |
Cerebral Palsy | 0.6 | -0.6 | |
Chronic Fatigue Syndrome | 0.7 | 0.1 | 6 |
Chronic Kidney Disease | 0.1 | 0 | 0 |
Chronic Lyme | 0.1 | -0.1 | |
Chronic Obstructive Pulmonary Disease (COPD) | 0 | 0 | |
Chronic Urticaria (Hives) | 0.1 | -0.1 | |
Coagulation / Micro clot triggering bacteria | 0.5 | -0.5 | |
Colorectal Cancer | 0.7 | 0.7 | |
Constipation | 0.1 | 0.1 | |
Coronary artery disease | 0.5 | 0 | 0 |
COVID-19 | 0.6 | 1.5 | -1.5 |
Crohn's Disease | 0.7 | 0.7 | 0 |
cystic fibrosis | 0.1 | -0.1 | |
deep vein thrombosis | 0.5 | -0.5 | |
Depression | 0.6 | 0.6 | 0 |
Eczema | 0.1 | -0.1 | |
Endometriosis | 0.1 | 0.5 | -4 |
Epilepsy | 0.2 | 0.1 | 1 |
Fibromyalgia | 0.1 | -0.1 | |
Functional constipation / chronic idiopathic constipation | 0.7 | 0.2 | 2.5 |
gallstone disease (gsd) | 0.5 | 0.5 | |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.1 | 0.1 | |
Generalized anxiety disorder | 0.1 | -0.1 | |
Gout | 0 | 0 | |
Graves' disease | 0.1 | 0.1 | |
Halitosis | 0.1 | 0.1 | |
Hashimoto's thyroiditis | 0.1 | 0.1 | 0 |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.1 | 0.1 | |
hyperglycemia | 0.1 | -0.1 | |
hypertension (High Blood Pressure | 0.6 | 0.2 | 2 |
Hypothyroidism | 0 | 0 | |
Hypoxia | 0.1 | 0.1 | |
Inflammatory Bowel Disease | 0.2 | 1.7 | -7.5 |
Insomnia | 0.1 | 0.1 | 0 |
Intelligence | 0 | 0 | |
Intracranial aneurysms | 0.6 | 0.6 | |
Irritable Bowel Syndrome | 0.6 | 0.1 | 5 |
Liver Cirrhosis | 0.6 | 0.6 | 0 |
Long COVID | 0.1 | 1.5 | -14 |
Low bone mineral density | 0 | 0 | |
Lung Cancer | 0.5 | -0.5 | |
ME/CFS with IBS | 0.1 | -0.1 | |
ME/CFS without IBS | 0.1 | 0.1 | 0 |
Metabolic Syndrome | 0.7 | 0.7 | 0 |
Mood Disorders | 1.1 | 0.6 | 0.83 |
Multiple Sclerosis | 0.5 | 0.7 | -0.4 |
Multiple system atrophy (MSA) | 0.5 | -0.5 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.6 | -0.6 | |
Obesity | 0.6 | 0.6 | 0 |
obsessive-compulsive disorder | 1.2 | 0.1 | 11 |
Osteoarthritis | 0.1 | 0.5 | -4 |
Osteoporosis | 0.6 | 0.1 | 5 |
Parkinson's Disease | 0 | 0.6 | 0 |
Polycystic ovary syndrome | 0.6 | 1 | -0.67 |
Postural orthostatic tachycardia syndrome | 0 | 0 | |
Psoriasis | 0.6 | 0.1 | 5 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.6 | 0.2 | 2 |
Rosacea | 0.5 | 0.5 | |
Schizophrenia | 0.6 | 0.5 | 0.2 |
scoliosis | 0 | 0.5 | 0 |
Sjögren syndrome | 0.1 | -0.1 | |
Sleep Apnea | 0.5 | 0.1 | 4 |
Stress / posttraumatic stress disorder | 0.1 | 0.1 | 0 |
Systemic Lupus Erythematosus | 0.2 | 0.5 | -1.5 |
Tic Disorder | 0.5 | 0.5 | |
Tourette syndrome | 0.1 | -0.1 | |
Type 1 Diabetes | 0.7 | 0.7 | |
Type 2 Diabetes | 0.7 | 0.7 | 0 |
Ulcerative colitis | 0.1 | 0.1 | 0 |
Unhealthy Ageing | 0.2 | 0 | 0 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.